Clostridium difficile infection in outpatients, Maryland and Connecticut, USA, 2002-2007

Emerging Infectious Diseases

Volumn 17, Issue 10, 2011, Pages 1946-1949

  Hirshon, Jon Mark ^a   Thompson, Angela D ^b   Limbago, Brandi ^b   McDonald, L Clifford ^b   Bonkosky, Michelle ^b   Heimer, Robert ^c   Meek, James ^c   Mai, Volker ^d   Braden, Christopher ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CEFPODOXIME; CIPROFLOXACIN; CLINDAMYCIN; CLOSTRIDIUM TOXIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; SULTAMICILLIN; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOVIRUS; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASTROVIRUS; BACILLUS CEREUS; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM PERFRINGENS; COLON DISEASE; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FECES ANALYSIS; FEMALE; FOLLOW UP; HEALTH STATUS; HOOKWORM INFECTION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFANT; INTESTINE INFECTION; INTESTINE RESECTION; LUPUS VULGARIS; MALE; MEDICAL HISTORY; MICROBIAL IDENTIFICATION; MIXED INFECTION; NEOPLASM; NONHUMAN; NOROVIRUS; ORGAN TRANSPLANTATION; OUTPATIENT; PRESCHOOL CHILD; RISK FACTOR; ROTAVIRUS; SAPOVIRUS; SCHOOL CHILD; ULCERATIVE COLITIS; UNITED STATES;

EID: 84930484891     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1710.110069     Document Type: Article

References (15)

1. Herikstad H, Yang S, Van Gilder TJ, Vugia D, Hadler J, Blake P, et al. A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996-7. Epidemiol Infect. 2002;129:9-17. doi:10.1017/S0950268801006628
2. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med. 2008;359:1932-40. doi:10.1056/NEJMra0707500
3. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28:140-5. Epub 2007 Jan 25. doi:10.1086/511798
4. Nataro JP, Mai V, Johnson J, Blackwelder WC, Heimer R, Tirrell S, et al. Diarrheagenic E. coli in Baltimore and New Haven. Clin Infect Dis. 2006;43:402-7. Epub 2006 Jul 11. doi:10.1086/505867
5. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmée M. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol. 1998;36:2240-7.
6. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett. 2000;186:307-12. doi:10.1111/j.1574-6968.2000.tb09122.x
7. Killgore G, Thompson A, Johnson S, Brazier J, Kuijper E, Pepin J, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol. 2008;46:431-7. Epub 2007 Nov 26. doi:10.1128/JCM.01484-07
8. Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis. 2007;45:222-7. Epub 2007 Jun 4. doi:10.1086/518874
9. Centers for Disease Control and Prevention. Surveillance for community-associated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep. 2008;57:340-3.
10. Karlström O, Fryklund B, Tullus K, Burman LG, and the Swedish C. difficile Study Group. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. Clin Infect Dis. 1998;26:141-5. doi:10.1086/516277
11. Kutty PK, Benoit SR, Woods CW, Sena AC, Naggie S, Frederick J, et al. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol. 2008;29:197-202. doi:10.1086/528813
12. Lambert PJ, Dyck M, Thompson LH, Hammond GW. Populationbased surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Infect Control Hosp Epidemiol. 2009;30:945-51. doi:10.1086/605719
13. Bauer MP, Veenendaal D, Verhoef L, Bloembergen P, van Dissel JT, Kuijper EJ. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. Clin Microbiol Infect. 2009;15:1087-92. doi:10.1111/j.1469-0691.2009.02853.x
14. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A casecontrol study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008;62:388-96. doi:10.1093/jac/dkn163
15. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-55. doi:10.1086/651706